Among them, HALP score, calculated as Hemoglobin (g/L) × Albumin (g/L) × Lymphocyte (/L)/Platelet (/L), was reported to be related to survival in gastric cancer, colorectal cancer, bladder cancer, and renal cancer patients [18,19,20]. This evidence concerns the gene ALB and urinary bladder cancer.